Targeting Serotonin 5-HT2A Receptors to Better Treat Schizophrenia: Rationale and Current Approaches.

Saved in:
Bibliographic Details
Title: Targeting Serotonin 5-HT2A Receptors to Better Treat Schizophrenia: Rationale and Current Approaches.
Authors: Kantrowitz JT; Department of Psychiatry, Columbia University, 1051 Riverside Drive, New York, NY, USA. jk3380@cumc.columbia.edu.; Department of Psychiatry, New York State Psychiatric Institute, 1051 Riverside Drive, New York, NY, 10032, USA. jk3380@cumc.columbia.edu.; Nathan S. Kline Institute for Psychiatric Research, 140 Old Orangeburg Rd, Orangeburg, NY, 10914, USA. jk3380@cumc.columbia.edu.
Source: CNS drugs [CNS Drugs] 2020 Sep; Vol. 34 (9), pp. 947-959.
Publication Type: Journal Article; Review
Journal Info: Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 9431220 Publication Model: Print Cited Medium: Internet ISSN: 1179-1934 (Electronic) Linking ISSN: 11727047 NLM ISO Abbreviation: CNS Drugs Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1179-1934
DOI:10.1007/s40263-020-00752-2